Today's News | Note: News feeds may no longer be available for the articles on this page.

Glaxo to Market Amgen Osteoporosis Drug in Europe 9:32 AM 7/28/2009
Bloomberg
Amgen and GlaxoSmithKline will jointly market Amgen’s novel treatment denosumab for osteoporosis that may reach annual sales of $2 billion within a decade. ...

FDA Heat Fails to Scorch Appeal of Indian Pharma 5:39 AM 7/28/2009
Wall Street Journal
These companies are scrambling to improve standards and will be in a better position to increase business over the next five years when $100 billion worth of drugs go off-patent. ...

Sanofi buys into Indian biotech 3:35 AM 7/28/2009
Financial Times
Sanofi-Aventis made its first direct investment in the Indian biotech sector with the acquisition of the major share of vaccine maker Shantha Biotechnics for $613 million. ...

Drugs work best when swine flu found early: study 4:32 PM 7/27/2009
Reuters - USA
A delay of more than 24 hours could make both antiviral treatment and prophylaxis ineffective. ...

How Biotech Hurts Health Care 3:33 PM 7/27/2009
BusinessWeek
The US government shouldn't be creating a road map to biosimilars to reform the country's health-care system. ...

Lilly, BioMS scrap MS drug after trial fails 2:22 PM 7/27/2009
Reuters - USA
Eli Lilly and BioMS Medical Corp said their experimental dirucotide drug for multiple sclerosis failed to delay progression of the disease in a late-stage trial. All ongoing studies of the product are discontinued. ...

FDA gives Tranzyme Pharma drug fast-track status 12:00 PM 7/27/2009
Bizjournals.com - Charlotte,NC,USA
The US FDA gave fast-track status to Tranzyme Pharma drug TZP-102, an oral treatment for gastroparesis in diabetic patients. ...

Ariad Pharma says cancer drug shows promise 8:00 AM 7/27/2009
Reuters - USA
Ariad Pharmaceuticals Inc said preliminary results from a early-stage trial on an investigational drug showed significant activity in patients with chronic myeloid leukemia (CML) resistant to other drugs. ...

Mega Mergers Can't Cure the Pharmaceutical Industry 5:21 AM 7/27/2009
BusinessWeek - USA
Forget takeovers. Collaboration on research and development is the future of the industry. Merck and AstraZeneca combine pipeline products to develop an innovative cancer therapy. GlaxoSmithKline and Concert Pharmaceuticals pool assets to distribute risk. ...

Diabetes drug Avandia comes under new criticism 7:47 AM 7/26/2009
Los Angeles Times
Activist group Public Citizen said diabetes drug rosiglitazone can produce liver failure and death in some patients. ...

The Little Biotech That Could 5:56 AM 7/25/2009
Barron's - USA
OSI Pharmaceuticals is poised to grow market share as it expands the uses for lung-cancer drug Tarceva (erlotinib). Hitting $1 billion in sales co-marketed with Roche/Genentech in a 50/50 split and 21% royalty on international sales. ...

Rigel says rheumatoid arthritis drug missed goal 7:25 AM 7/24/2009
Forbes - NY,USA
Rigel Pharmaceuticals said its rheumatoid arthritis drug candidate R788 did not reach its goals in a mid-stage clinical trial. ...

After Medarex buy, biotech investors ask who's next 2:18 PM 7/23/2009
Reuters - USA
Investors bid up shares of Regeneron Pharmaceuticals Inc and Seattle Genetics Inc after Medarex Inc agreed to be acquired by Bristol-Myers Squibb Co in a $2.4 billion deal. ...

Allergan eye surgery drug gets FDA approval 12:01 PM 7/23/2009
The Associated Press
Allergan Inc said it received US FDA approval for its post-cataract surgery eye solution Acuvail expected to reach the market in September. ...

Bristol-Myers to buy Medarex for $2.4 billion 5:38 AM 7/23/2009
Reuters - USA
Bristol-Myers Squibb Co will pay $2.4 billion to acquire biotech company Medarex Inc. The two have been cooperating on a promising treatment for melanoma since 2005. ...

<- Day Earlier | Today's News